Macquarie Group LTD Merck & Co., Inc. Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
A detailed history of Macquarie Group LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 4,487,785 shares of MRK stock, worth $510 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
4,487,785
Previous 4,955,422
9.44%
Holding current value
$510 Million
Previous $654 Million
15.03%
% of portfolio
0.65%
Previous 0.75%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,830Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$27.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$23.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.4 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.24 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.48 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $288B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...